Medicinal plants are used throughout the world, and the regulations defining their proper use, such as identification of the correct species and verification of the presence, purity and concentration of the required chemical compounds, are widely recognized. Herbal medicines are made from vegetal drugs, the processed products of medicinal species. These processed materials present a number of challenges in terms of botanical identification, and according to the World Health Organization (WHO), the use of incorrect species is a threat to consumer safety. The samples used in this study consisted of the dried leaves, flowers and roots of 257 samples from 8 distinct species approved by the WHO for the production of medicinal herbs and sold in Brazilian markets. Identification of the samples in this study using DNA barcoding (matK, rbcL and ITS2 regions) revealed that the level of substitutions may be as high as 71%. Using qualitative and quantitative chemical analyses, this study identified situations in which the correct species was being sold, but the chemical compounds were not present. Even more troubling, some samples identified as substitutions using DNA barcoding contained the chemical compounds from the correct species at the minimum required concentration. This last situation may lead to the use of unknown species or species whose safety for human consumption remains unknown. This study concludes that DNA barcoding should be used in a complementary manner for species identification with chemical analyses to detect and quantify the required chemical compounds, thus improving the quality of this class of medicines.

RESUMO: "Plantas medicinais e outros produtos vegetais da Farmacopéia Brasileira". Este artigo descreve os resultados de uma extensa revisão efetuada nas quatro edições da Farmacopéia Brasileira, buscando dados sobre as plantas medicinais e outros produtos vegetais nela descritos. O crescimento da indústria farmacêutica internacional a partir da segunda metade do século passado afetou intensamente a medicina ofi cial no Brasil. O texto faz uma breve análise das transformações sofridas pela Farmacopéia, tomando como base a existência de Monografi as para as espécies vegetais nativas. Os resultados do estudo demonstram uma intensa substituição das plantas nativas do Brasil por medicamentos industrializados e outros produtos vegetais estrangeiros, confi rmando assim a necessidade de investimentos em pesquisa de validação das nossas plantas medicinais.Unitermos: Farmacopéia Brasileira, plantas medicinais, Brasil. ABSTRACT:In this paper, we describe the results of a thorough survey in the four editions of the Brazilian Offi cial Pharmacopoeia (FBRAS), in a search for data about the plants and other botanical products included in them. The growth of the pharmaceutical industry since the second half of last century markedly affected the Brazilian offi cial medicine. The paper analyses the transformation within the Pharmacopoeia, focusing on the presence of Monographs for Native medicinal plants. The result showed a strong substitution of Native American medicinal plants by industrialized medicine and foreign medicinal plants in FBRAS and confi rms the necessity of investiments in research for the validation of Brazilian Native plants.

RESUMO: "Usos tradicionais das plantas Americanas presentes na 1ª Edição da FarmacopéiaBrasileira". A 1ª Edição da Farmacopéia Brasileira, publicada em 1929, é uma rica fonte de informação sobre as plantas medicinais nativas das Américas, uma vez que ela lista as espécies usadas na medicina tradicional e oficial da época. Neste estudo, foi feita uma extensa revisão sobre os usos tradicionais de plantas descritas em oitenta e sete Monografias presentes na FBRAS 1ª Edição, em vinte livros publicados do século 19 até a década de 1970. Oitenta e seis diferentes usos medicinais foram citados e três ou mais livros; mesmos usos foram descritos em dez ou mais referências, mostrando seu amplo emprego e importância como medicamento. Os resultados mostram que as espécies nativas presentes na 1ª Edição da FBRAS têm longa tradição em uso, confirmado pelos dados históricos. É necessário, portanto, que estudos farmacológicos com essas plantas sejam estimulados, como forma de promover seu melhor aproveitamento.Unitermos: Plantas nativas da América, Farmacopéia, usos tradicionais. ABSTRACT:The first edition of the Brazilian Official Pharmacopoeia (FBRAS), published in 1929, is a rich source of information about American medicinal plants, since it lists species used in both traditional and conventional medicine. In this study, we have performed a survey of the traditional uses of plants described in eighty-seven Monographs from the FBRAS in twenty bibliographies written from the 19 th century to the 1970s. Eighty-six different traditional uses are described in three or more books; some of them were cited in ten or more books, illustrating their widespread use and importance in medicine. The species from the first edition of the FBRAS have a long tradition of medical utility, which is confirmed by historical records. In surveying these medically relevant species, we hope to encourage policy makers and the scientific public as a whole to engage in a strong debate in an attempt to improve and facilitate the pharmacological study of these species.

No abstract

This study shows that several bitter species named quina were used in the past as substitute of Cinchona spp. and studying these plants can lead to the development of new products.